WBB Securities is pleased to share a featured interview with our Managing Director, Dr. Steve Brozak, published in The Wall Street Transcript on April 29, 2025.
Read More about Onshoring Drug Manufacturing Is Critical But Not Easy
Pharmaceutical tariffs are looming again, and the stakes are higher than ever.
Read More about Pharma Dodges The Tariff Bullet—But For How Long?The Trump administration just levied tariffs on China, Mexico, and Canada with a message: it’s not about trade, it’s about fentanyl.
Read More about As Tariffs Begin; What Will They Do To Drug Prices And Availability?The Need for Novel Responses to Disease Threats in a Fast-Changing World.
Read More about Dr. Steve Brozak, President of WBB Securities, will moderate a panel at the Biotech Showcase Conference on Wednesday, January 15, 2025, titled “The Need for Novel Responses to Disease Threats in a Fast-Changing World.”Is RFK Jr. the answer for U.S. healthcare reform? Dr. Brozak’s Forbes article outlines five key signs that indicate possible major changes under RFK Jr.’s influence.
Read More about Is RFK Jr. Just What The Doctor Ordered? 5 Ways He Could Heal HealthcareThe musical Lifeline not only entertains but educates on one of the greatest health challenges of our time—antimicrobial resistance. This Forbes article explores how the arts and AI-powered diagnostics are raising awareness and driving change. A must-read for anyone interested in the future of medicine.
Read More about Lifeline, A Musical That Raises The Alarm On Antimicrobial Resistance